Atlas FDA

STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON

FDA premarket approval P160049 · decided 2017-07-26

Approval details

PMA number
P160049
Trade name
STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Generic name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Applicant
The Spectranetics Corp.
Date received
2016-11-02
Decision date
2017-07-26
Days to decision
266 days
Decision code
APPR
Product code
ONU
Advisory committee
Cardiovascular
Expedited review
No
Location
Fremont, CA
Statement
Approval of the Stellarex 0.035 OTW Drug-coated Angioplasty Balloon. This device is indicated for percutaneous transluminal angioplasty (PTA), after appropriate vessel preparation, of de novo or restenotic lesions up to 180 mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4-6 mm.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.